首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   7557篇
  免费   693篇
  国内免费   3篇
  2022年   46篇
  2021年   85篇
  2020年   68篇
  2019年   66篇
  2018年   110篇
  2017年   98篇
  2016年   155篇
  2015年   266篇
  2014年   319篇
  2013年   359篇
  2012年   524篇
  2011年   471篇
  2010年   312篇
  2009年   275篇
  2008年   407篇
  2007年   438篇
  2006年   410篇
  2005年   388篇
  2004年   390篇
  2003年   358篇
  2002年   350篇
  2001年   120篇
  2000年   107篇
  1999年   118篇
  1998年   118篇
  1997年   79篇
  1996年   75篇
  1995年   85篇
  1994年   99篇
  1993年   98篇
  1992年   94篇
  1991年   83篇
  1990年   86篇
  1989年   61篇
  1988年   67篇
  1987年   63篇
  1986年   57篇
  1985年   59篇
  1984年   71篇
  1983年   45篇
  1982年   51篇
  1981年   46篇
  1980年   51篇
  1979年   54篇
  1978年   47篇
  1977年   34篇
  1974年   44篇
  1973年   31篇
  1972年   36篇
  1969年   33篇
排序方式: 共有8253条查询结果,搜索用时 156 毫秒
911.
Rotaviruses are a major cause of acute gastroenteritis in children worldwide. Early stages of rotavirus assembly in infected cells occur in viroplasms. Confocal microscopy demonstrated that viroplasms associate with lipids and proteins (perilipin A, ADRP) characteristic of lipid droplets (LDs). LD-associated proteins were also found to colocalize with viroplasms containing a rotaviral NSP5-enhanced green fluorescent protein (EGFP) fusion protein and with viroplasm-like structures in uninfected cells coexpressing viral NSP2 and NSP5. Close spatial proximity of NSP5-EGFP and cellular perilipin A was confirmed by fluorescence resonance energy transfer. Viroplasms appear to recruit LD components during the time course of rotavirus infection. NSP5-specific siRNA blocked association of perilipin A with NSP5 in viroplasms. Viral double-stranded RNA (dsRNA), NSP5, and perilipin A cosedimented in low-density gradient fractions of rotavirus-infected cell extracts. Chemical compounds interfering with LD formation (isoproterenol plus isobutylmethylxanthine; triacsin C) decreased the number of viroplasms and inhibited dsRNA replication and the production of infectious progeny virus; this effect correlated with significant protection of cells from virus-associated cytopathicity. Rotaviruses represent a genus of another virus family utilizing LD components for replication, pointing at novel therapeutic targets for these pathogens.Rotaviruses are a major cause of acute gastroenteritis in infants and young children, producing a high burden of disease worldwide and over 600,000 deaths per annum, mainly in developing countries (43). Recently, two live attenuated rotavirus vaccines (49, 58) have been licensed in various countries, and their widespread use in universal mass vaccination programs is being implemented (55).Rotaviruses form a genus of the Reoviridae family. They contain a genome of 11 segments of double-stranded RNA (dsRNA) encoding six structural proteins (VP1, VP2, VP3, VP4, VP6, and VP7) and six nonstructural proteins (NSP1 to NSP6). After entry into the host cell the outer layer of the triple-layered particles (TLPs; infectious virions) is removed in endocytic vesicles, and the resulting double-layered particles (DLPs) actively transcribe mRNAs from the 11 RNA segments and release them into the cytoplasm. The mRNAs are translated into proteins but also act as templates for dsRNA synthesis (RNA replication). The early stages of viral morphogenesis and viral RNA replication occur in cytoplasmic inclusion bodies termed “viroplasms.” Partially assembled DLPs are released from viroplasms and receive their outer layer in the rough endoplasmic reticulum (RER), forming TLPs (for details, see Estes and Kapikian [20]).The rotavirus nonstructural proteins NSP2 and NSP5 are major components of viroplasms (20, 47). These two proteins alone are sufficient to induce the formation of viroplasm-like structures (VLS) (21). Blocking of either NSP2 or NSP5 in rotavirus-infected cells significantly reduces viroplasm formation and the production of infectious viral progeny (11, 54, 57). Until now, host cell proteins involved in viroplasm formation have not been identified.Morphological similarities between viroplasms and lipid droplets (LDs) prompted us to investigate their relationship. Both structures have phosphoproteins (NSP5 and perilipin A, respectively) inserted on their surface in ringlike shapes (16, 34). LDs are intracellular organelles involved in lipid and carbohydrate metabolism. They consist of a neutral lipid core surrounded by a phospholipid monolayer containing LD-associated proteins; those include proteins of the PAT family consisting of perilipin, adipophilin (adipose differentiation-related protein [ADRP]), and TIP-47 (9, 37). Lipolysis from LDs is regulated by hormones such as catecholamines, which trigger the phosphorylation of hormone-sensitive lipase (HSL) and perilipin A and induce LD fragmentation. Incubating adipocytes with the β-adrenergic agonist isoproterenol and the phosphodiesterase inhibitor isobutylmethylxanthine (IBMX) activates this pathway (27, 34). LD formation can also be blocked by triacsin C, a specific inhibitor of long chain acyl coenzyme A synthetases (30, 39).We demonstrate here that rotavirus viroplasms colocalize with the LD-associated proteins perilipin A and ADRP and also with the lipids of LDs. These interactions appear to be required for the formation of functional viroplasms and the production of infectious viral progeny, since compounds dispersing LDs or blocking LD formation significantly decrease the number and size of viroplasms and the amount of infectious progeny. Taken together, these findings strongly suggest a critical role of LDs in rotavirus replication.  相似文献   
912.
The chloroviruses (family Phycodnaviridae), unlike most viruses, encode some, if not most, of the enzymes involved in the glycosylation of their structural proteins. Annotation of the gene product B736L from chlorovirus NY-2A suggests that it is a glycosyltransferase. The structure of the recombinantly expressed B736L protein was determined by X-ray crystallography to 2.3-Å resolution, and the protein was shown to have two nucleotide-binding folds like other glycosyltransferase type B enzymes. This is the second structure of a chlorovirus-encoded glycosyltransferase and the first structure of a chlorovirus type B enzyme to be determined. B736L is a retaining enzyme and belongs to glycosyltransferase family 4. The donor substrate was identified as GDP-mannose by isothermal titration calorimetry and was shown to bind into the cleft between the two domains in the protein. The active form of the enzyme is probably a dimer in which the active centers are separated by about 40 Å.Glycosyltransferases constitute a large family of enzymes that catalyze the transfer of sugar moieties from donor molecules to specific acceptor molecules. Unlike other enzyme families that usually share conserved features in their primary sequences, glycosyltransferases can have highly diversified sequences that have been grouped into more than 90 families (designated GTn, where n = 1, 2, …) (http://www.CAZy.org) (1, 15). However, two families, GT2 and GT4, account for about half of the total number of glycosyltransferases. Despite the large variation in the primary sequences of glycosyltransferases, their three-dimensional structures are usually conserved. There are two major glycosyltransferase structural types, named GT-A and GT-B. The GT-A members contain a single nucleotide-binding domain consisting of six parallel β-strands flanked by connecting α-helices (referred to as a “Rossmann fold” in most of the literature on these enzymes and herein). GT-A enzyme activities are usually metal ion dependent. The GT-B type glycosyltransferases have two Rossmann folds separated by a cleft that forms the substrate-binding site. Metal ions are normally not required for GT-B function. Based on their catalytic mechanism, glycosyltransferases are also classified as either retaining or inverting enzymes depending on the geometry between the sugar donor and the receptor in the product molecule (e.g., depending on whether the anomeric carbon atom is linked to the acceptor via its α or β position). If the anomeric carbon atom has the same configuration in the donor and in the product, the enzyme is classified as a retaining enzyme; if the configurations are different, the enzyme is considered to be an inverting enzyme (2).Many viruses, especially those that infect eukaryotic cells, have extensively glycosylated structural proteins. Glycans coating viral structural proteins serve multiple biological roles, e.g., they mimic host glycans to evade host cell immune reactions, aid in folding or assembly of viral structural proteins, function as a receptor recognized by cell surface proteins, or aid in stabilizing viral particles (see, e.g., reference 36).Typically, viruses use host-encoded glycosyltransferases and glycosidases located in the endoplasmic reticulum (ER) and Golgi apparatus to add and remove N-linked sugar residues from virus glycoproteins either during or shortly after translation of the protein. This posttranslational processing aids in protein folding and requires other host-encoded enzymes. After folding and assembly, virus glycoproteins are transported by host-sorting and membrane transport functions to virus-specified regions in host membranes, where they displace host glycoproteins. Progeny viruses then bud through these virus-specific target membranes, in what is usually the final step in the assembly of infectious virions (3, 14, 21, 36). Thus, nascent viruses become infectious only by budding through the target membrane, usually the plasma membrane, as they are released from the cell. Consequently, the glycan portion of virus glycoproteins is host specific. The theme that emerges is that virus glycoproteins are synthesized and glycosylated by the same mechanisms as host glycoproteins. Therefore, the only way to alter glycosylation of virus proteins is to either grow the virus in a different host or have a mutation in the virus protein that alters the protein glycosylation site.One explanation for this scenario is that, in general, viruses lack genes encoding glycosyltransferases. However, a few virus-encoded glycosyltransferases have been reported in recent years (see reference 17 for a review). Often these virus-encoded glycosyltransferases add sugars to compounds other than proteins. For instance, some phage-encoded glycosyltransferases modify virus DNA to protect it from host restriction endonucleases (see, e.g., reference 10), and a glycosyltransferase encoded by baculoviruses modifies a host insect ecdysteroid hormone, leading to its inactivation (22). Bovine herpesvirus 4 encodes a β-1,6-N-acetyl-glucosaminyltransferase that is localized in the Golgi apparatus and is probably involved in posttranslational modification of the virus structural proteins (32).One group of viruses differs from the scenario that viruses use the host machinery located in the ER and the Golgi apparatus to glycosylate their glycoproteins. These viruses are the large, plaque-forming, double-stranded DNA (dsDNA)-containing chloroviruses (family Phycodnaviridae) that infect eukaryotic algae (4, 34, 39, 40). The chloroviruses have up to 400 protein-encoding genes (or coding sequences [CDSs]). Annotation of six chlorovirus genomes showed that each virus encodes 3 to 6 putative glycosyltransferases (7-9, 16, 33). Three of these viruses, NY-2A, AR158, and the prototype chlorovirus Paramecium bursaria chlorella virus 1 (PBCV-1), infect Chlorella strain NC64A. Two of the viruses, MT325 and FR483, infect Chlorella Pbi, and one of them, Acanthocystis turfacea chlorella virus (ATCV-1), infects Chlorella SAG 3.83.Glycosylation of the PBCV-1 major capsid protein, Vp54, is at least partially performed by the viral glycosyltransferases (11, 20, 33, 38, 41). PBCV-1 encodes 5 putative glycosyltransferases. A previous structural study established that the N-terminal 211 amino acids of the A64R protein from PBCV-1 form a GT-A group glycosyltransferase that is a retaining enzyme belonging to the GT34 family and that UDP-glucose possibly serves as the donor sugar (41).Among the four additional PBCV-1 glycosyltransferase-encoding genes, gene a546l encodes a 396-amino-acid protein that resembles members in the GT4 family of glycosyltransferases, based on amino acid sequence comparison of members in the CAZy classification (1, 15). Homologs of this protein, A546L, are encoded by 3 other chloroviruses, NY-2A, AR158, and ATCV-1. Here, we report the crystal structure of one of these homologs, B736L, at 2.3-Å resolution.  相似文献   
913.
914.
Fibroblast growth factor (FGF) signaling regulates mammalian development and metabolism, and its dysregulation is implicated in many inherited and acquired diseases, including cancer. Heparan sulfate glycosaminoglycans (HSGAGs) are essential for FGF signaling as they promote FGF·FGF receptor (FGFR) binding and dimerization. Using novel organic synthesis protocols to prepare homogeneously sulfated heparin mimetics (HM), including hexasaccharide (HM6), octasaccharide (HM8), and decasaccharide (HM10), we tested the ability of these HM to support FGF1 and FGF2 signaling through FGFR4. Biological assays show that both HM8 and HM10 are significantly more potent than HM6 in promoting FGF2-mediated FGFR4 signaling. In contrast, all three HM have comparable activity in promoting FGF1·FGFR4 signaling. To understand the molecular basis for these differential activities in FGF1/2·FGFR4 signaling, we used NMR spectroscopy, isothermal titration calorimetry, and size-exclusion chromatography to characterize binding interactions of FGF1/2 with the isolated Ig-domain 2 (D2) of FGFR4 in the presence of HM, and binary interactions of FGFs and D2 with HM. Our data confirm the existence of both a secondary FGF1·FGFR4 interaction site and a direct FGFR4·FGFR4 interaction site thus supporting the formation of the symmetric mode of FGF·FGFR dimerization in solution. Moreover, our results show that the observed higher activity of HM8 relative to HM6 in stimulating FGF2·FGFR4 signaling correlates with the higher affinity of HM8 to bind and dimerize FGF2. Notably FGF2·HM8 exhibits pronounced positive binding cooperativity. Based on our findings we propose a refined symmetric FGF·FGFR dimerization model, which incorporates the differential ability of HM to dimerize FGFs.  相似文献   
915.
Fibronectin-binding proteins (FnBPs) of Staphylococcus aureus and Streptococcus pyogenes mediate invasion of human endothelial and epithelial cells in a process likely to aid the persistence and/or dissemination of infection. In addition to binding sites for the N-terminal domain (NTD) of fibronectin (Fn), a number of streptococcal FnBPs also contain an upstream region (UR) that is closely associated with an NTD-binding region; UR binds to the adjacent gelatin-binding domain (GBD) of Fn. Previously, UR was shown to be required for efficient streptococcal invasion of epithelial cells. Here we show, using a Streptococcus zooepidemicus FnBP, that the UR-binding site in GBD resides largely in the 8F19F1 module pair. We also show that UR inhibits binding of a peptide from the α1 chain of type I collagen to 8F19F1 and that UR binding to 8F1 is likely to occur through anti-parallel β-zipper formation. Thus, we propose that streptococcal proteins that contain adjacent NTD- and GBD-binding sites form a highly unusual extended tandem β-zipper that spans the two domains and mediates high affinity binding to Fn through a large intermolecular interface. The proximity of the UR- and NTD-binding sequences in streptococcal FnBPs is consistent with a non-linear arrangement of modules in the tertiary structure of the GBD of Fn.  相似文献   
916.
917.
A lack of initial stability of the fixation is associated with aseptic loosening of the tibial components of cementless knee prostheses. With sufficient stability after surgery, minimal relative motion between the prosthesis and bone interfaces allows osseointegation to occur thereby providing a strong prosthesis-to-bone biological attachment. Finite element modelling was used to investigate the bone–prosthesis interface micromotion and the relative risk of aseptic loosening. It was anticipated that by prescribing different joint loads representing gait and other activities, and the consideration of varying tibial–femoral contact points during knee flexion, it would influence the computational prediction of the interface micromotion. In this study, three-dimensional finite element models were set up with applied loads representing walking and stair climbing, and the relative micromotions were predicted. These results were correlated to in-vitro measurements and to the results of prior retrieval studies. Two load conditions, (i) a generic vertical joint load of 3×body weight with 70%/30% M/L load share and antero-posterior/medial-lateral shear forces, acted at the centres of the medial and lateral compartments of the tibial tray, and (ii) a peak vertical joint load at 25% of the stair climbing cycle with corresponding antero-posterior shear force applied at the tibial–femoral contact points of the specific knee flexion angle, were found to generate interface micromotion responses which corresponded to in-vivo observations. The study also found that different loads altered the interface micromotion predicted, so caution is needed when comparing the fixation performance of various reported cementless tibial prosthetic designs if each design was evaluated with a different loading condition.  相似文献   
918.
In the N2 domain of the gene-3-protein of phage fd, two consecutive β-strands are connected by a mobile loop of seven residues (157-163). The stability of this loop is low, and the Asp160-Pro161 bond at its tip shows conformational heterogeneity with 90% being in the cis and 10% in the trans form. The refolding kinetics of N2 are complex because the molecules with cis or trans isomers at Pro161 both fold to native-like conformations, albeit with different rates. We employed consensus design to shorten the seven-residue irregular loop around Pro161 to a four-residue type I′ turn without a proline. This increased the conformational stability of N2 by almost 10 kJ mol− 1 and abolished the complexity of the folding kinetics. Turn sequences obtained from in vitro selections for increased stability strongly resembled those derived from the consensus design. Two other type I′ turns of N2 could also be stabilized by consensus design. For all three turns, the gain in stability originates from an increase in the rate of refolding. The turns form native-like structures early during refolding and thus stabilize the folding transition state. The crystal structure of the variant with all three stabilized turns confirms that the 157-163 loop was in fact shortened to a type I′ turn and that the other turns maintained their type I′ conformation after sequence optimization.  相似文献   
919.
A copper(I) complex of 2-aminobenzenethiol, [Cu(abt)] (1), has been synthesized and characterized. The crystal structure determination indicates a two-dimensional metallopolymeric network formed by edge and corner sharing [Cu(μ3-S)N] coordination tetrahedra wherein the copper(I) centers are coordinated to three bridging thiolate donors and the amino group of 2-aminobenzenethiolate. The copper, the sulfur and the nitrogen atoms form sub-lattices that reveal independently striking similarities to the double-layers present in black phosphorus.  相似文献   
920.
Two dimeric head-on complexes of yttrium containing silico- and germanotungstate were isolated from the one-pot reaction of Y(NO3)3·6H2O with the lacunary Na10[MW9O34]·16H2O (M = Si and Ge) building blocks in an acetate buffer at pH 4.5. Both polyanions were structurally characterized using various solid-state analytics, such as single-crystal X-ray diffraction, single-crystal X-ray analysis shows that both polyanions crystallize in the monoclinic crystal system (S.G. P21/c). FT-IR spectroscopy, or thermogravimetric analysis. The stability of the polyanion in aqueous solution was studied by multinuclear NMR spectroscopy (183W, 89Y, 29Si, 13C, and 1H). As expected, the 183W NMR spectra display six peaks in the intensity ratio of 4:4:2:4:4:4 which indicates that both polyanions exist as dimeric entities in aqueous solution.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号